NVIV - InVivo Therapeutics Holdings Corp.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Cash Flow

Annual
All numbers in thousands
Period Ending12/31/201712/31/201612/31/2015
Net Income-26,745-23,438-33,314
Operating Activities, Cash Flows Provided By or Used In
Depreciation395548684
Adjustments To Net Income6,6024,78115,676
Changes In Accounts Receivables---
Changes In Liabilities-1671,960-327
Changes In Inventories---
Changes In Other Operating Activities232-591952
Total Cash Flow From Operating Activities-19,683-16,740-16,329
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures-65-107-5
Investments11,577-6,401-5,274
Other Cash flows from Investing Activities---
Total Cash Flows From Investing Activities11,512-6,508-5,279
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid---
Sale Purchase of Stock4030,18723,337
Net Borrowings-423-395-268
Other Cash Flows from Financing Activities---
Total Cash Flows From Financing Activities-38329,79223,069
Effect Of Exchange Rate Changes---
Change In Cash and Cash Equivalents-8,5546,5441,461